Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20095089 | 0.84 | GAA (0.41) | GAAL3MBTL1HTTKDM4EALDH1A1 | |
| SCHEMBL16710266 | 0.83 | GAA (0.40) | GAAL3MBTL1HTTKDM4EALDH1A1 | |
| SCHEMBL12259035 | 0.81 | GAA (0.46) | GAAL3MBTL1HTTKDM4EALDH1A1 | |
| SCHEMBL11528358 | 0.80 | — | — | |
| SCHEMBL11311068 | 0.76 | ESR1 (0.35) | GAAL3MBTL1HTTALDH1A1 | |
| SCHEMBL4433197 | 0.75 | GAA (0.34) | GAAL3MBTL1HTT | |
| SCHEMBL18560467 | 0.75 | GAA (0.44) | GAAL3MBTL1HTTKDM4EALDH1A1 | |
| SCHEMBL271984 | 0.75 | GAA (0.44) | GAAL3MBTL1HTTKDM4EALDH1A1 | |
| SCHEMBL25452963 | 0.74 | — | — | |
| SCHEMBL18627275 | 0.73 | GAA (0.43) | GAAL3MBTL1HTTKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4419580-B1 | METHOD FOR PROMOTING HYDROSILYLATION REACTION TO PREPARE ESTER-FUNCTIONAL SILOXANE OLIGOMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-08-27 | — | — | EP | disclosed |
| US-12398270-B2 | Acrylate-functional branched organosilicon compound, method of preparing same, and copolymer formed therewith | DOW SILICONES CORPORATION (US) | 2025-08-26 | — | — | US | disclosed |
| US-12378264-B2 | Multifunctional organosilicon compound and related methods, compounds, and compositions | DOW SILICONES CORPORATION (US) | 2025-08-05 | — | — | US | disclosed |
| US-12371535-B2 | Branched organosilicon compound, method of preparing same, and copolymer formed therewith | DOW SILICONES CORPORATION (US) | 2025-07-29 | — | — | US | disclosed |
| EP-4172165-B1 | PREPARATION OF MULTIFUNCTIONAL ORGANOSILICON COMPOUNDS | DOW SILICONES CORP (US) | 2025-07-23 | — | — | EP | disclosed |
| US-20250136763-A1 | SILICONE - VINYLESTER FUNCTIONAL COMPOUNDS AND METHODS FOR THEIR PREPARATION AND USE IN PERSONAL CARE COMPOSITIONS | DOW SILICONES CORP (US) | 2025-05-01 | — | — | US | disclosed |
| EP-4530323-A1 | CURABLE COMPOSITION FOR INKJET FOR METAL-CONTAINING BASE MATERIAL, SOLDER RESIST, AND INKJET RECORDING METHOD | KONICA MINOLTA, INC. (JP) | 2025-04-02 | — | — | EP | disclosed |
| US-20250101247-A1 | CURABLE COMPOSITION FOR INKJET FOR METAL-CONTAINING BASE MATERIAL, SOLDER RESIST, AND INKJET RECORDING METHOD | Konica Minolta, Inc. (JP) | 2025-03-27 | — | — | US | disclosed |
| EP-4508106-A1 | SILICONE - VINYLESTER FUNCTIONAL COMPOUNDS AND METHODS FOR THEIR PREPARATION AND USE IN PERSONAL CARE COMPOSITIONS | Dow Global Technologies LLC (US) | 2025-02-19 | — | — | EP | disclosed |
| EP-4508054-A1 | PREPARATION OF ORGANOSILICON COMPOUNDS WITH VINYLESTER FUNCTIONALITY | Dow Global Technologies LLC (US) | 2025-02-19 | — | — | EP | disclosed |
| US-6458956-B1 | ONE NITROXYL RADICAL (DERIVATIVE), B) AT LEAST ONE PHENOL (DERIVATIVE) AND C) AT LEAST ONE CHEMICAL COMPOUND WHICH CONTAINS AT LEAST ONE PHOSPHORUS ATOM WHICH HAS THE OXIDATION STATE +3 IS PREFERABLY USED FOR STABILIZING COMPOUNDS FOR FREE | BAF AKTIENGESELLSCHAFT (DE) | 2002-10-01 | — | — | US | disclosed |
| EP-1013678-B1 | Process for compressing ethylenically unsatureted monomers | BASF AG (DE) | 2002-03-20 | — | — | EP | disclosed |
| US-6350827-B1 | PRESSURIZATION OF ETHYLENICALLY UNSATURATED MONOMERS WITHOUT CATALYST IN THE PRESENCE OF NITROXYL COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 2002-02-26 | — | — | US | disclosed |
| EP-1144353-A2 | METHOD FOR STABILIZING CHEMICAL COMPOUNDS CONTAINING AT LEAST ONE ETHYLENICALLY UNSATURATED BOND IN ORDER TO PREVENT UNDESIRABLE RADICAL POLYMERIZATION | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-17 | — | — | EP | disclosed |
| EP-1086939-A1 | Inhibitor composition | BASF AKTIENGESELLSCHAFT (DE) | 2001-03-28 | — | — | EP | disclosed |
| US-6200460-B1 | MIXTURE COMPRISING VINYL AROMATIC COMPOUND, ACTIVE AMOUNT OF MIXTURE WHICH INHIBITS THE PREMATURE POLYMERIZATION OF SAID COMPOUND COMPRISING NOXYL COMPOUND, IRON COMPOUND, OPTIONALLY NITRO COMPOUNDS AND COSTABILIZERS | BASF AKTIENGESELLSCHAFT (DE) | 2001-03-13 | — | — | US | disclosed |
| EP-1077245-A2 | Inhibitor composition for stabilising radically polymerisable substances | BASF AKTIENGESELLSCHAFT (DE) | 2001-02-21 | — | — | EP | disclosed |
| WO-2000069793-A1 | MIXTURE OF SUBSTANCES, COMPRISING STABILISERS AND COMPOUNDS WHICH CONTAIN VINYL GROUPS | BASF AKTIENGESELLSCHAFT (DE) | 2000-11-23 | — | — | WO | disclosed |
| EP-1013678-A2 | Process for compressing ethylenically unsatureted monomers | BASF AKTIENGESELLSCHAFT (DE) | 2000-06-28 | — | — | EP | disclosed |
| WO-2000034220-A2 | METHOD FOR STABILIZING CHEMICAL COMPOUNDS CONTAINING AT LEAST ONE ETHYLENICALLY UNSATURATED BOND IN ORDER TO PREVENT UNDESIRABLE RADICAL POLYMERIZATION | BASF AKTIENGESELLSCHAFT (DE) | 2000-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12378264-B2 | Multifunctional organosilicon compound and related methods, compounds, and compositions | MSR1, OXSR1, RIOX2 | GAA 3021/4885L3MBTL1 1801/4885HTT 4383/4885 |
| US-20250136763-A1 | SILICONE - VINYLESTER FUNCTIONAL COMPOUNDS AND METHODS FOR THEIR PREPARATION AND USE IN PERSONAL CARE COMPOSITIONS | VCL, FANCF, MMS19 | GAA 2965/4885L3MBTL1 1707/4885HTT 1202/4885 |
| US-12371535-B2 | Branched organosilicon compound, method of preparing same, and copolymer formed therewith | OXSR1, BRS3, OXER1 | GAA 4550/4885L3MBTL1 3959/4885HTT 4358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.